Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giuliano

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Oncogene|August 1, 1996
SV40-like sequences in human bone tumorsM Carbone, P Rizzo, A Procopio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
The Journal of Organic Chemistry|December 15, 2018
Synthesis and Biological Evaluation of 6-[(1 R)-1-Hydroxyethyl]-2,4a( R),6( S),8a( R)-tetrahydropyrano-[3,2- b]-pyran-2-one and Structural Analogues of the Putative Structure of DiplopyroneNicholas C Lazzara, Robert J Rosano, Purav P Vagadia, et al.
Journal of Cancer|June 22, 2016
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast CancerM Mego, H Gao, E N Cohen, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
ESMO Open|February 18, 2021
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)C De Angelis, D Bruzzese, A Bernardo, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 28, 2017
Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unitK Van Naarden Braun, R Grazel, R Koppel, et al.
NPJ Breast Cancer|December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapyS Pizzamiglio, A Blanda, V Appierto, et al.
ESMO Open|October 8, 2025
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancerF Jacobs, S D'Amico, E Ferraro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2026
Allergic rhinitis in the elderly. In collaboration with ARIA guidelinesJean Bousquet, Maria Teresa Ventura, Luis Taborda-Barata, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Oncogene|August 1, 1996
SV40-like sequences in human bone tumorsM Carbone, P Rizzo, A Procopio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
The Journal of Organic Chemistry|December 15, 2018
Synthesis and Biological Evaluation of 6-[(1 R)-1-Hydroxyethyl]-2,4a( R),6( S),8a( R)-tetrahydropyrano-[3,2- b]-pyran-2-one and Structural Analogues of the Putative Structure of DiplopyroneNicholas C Lazzara, Robert J Rosano, Purav P Vagadia, et al.
Journal of Cancer|June 22, 2016
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast CancerM Mego, H Gao, E N Cohen, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
ESMO Open|February 18, 2021
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)C De Angelis, D Bruzzese, A Bernardo, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 28, 2017
Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unitK Van Naarden Braun, R Grazel, R Koppel, et al.
NPJ Breast Cancer|December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapyS Pizzamiglio, A Blanda, V Appierto, et al.
ESMO Open|October 8, 2025
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancerF Jacobs, S D'Amico, E Ferraro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2026
Allergic rhinitis in the elderly. In collaboration with ARIA guidelinesJean Bousquet, Maria Teresa Ventura, Luis Taborda-Barata, et al.
Pageof 18